Cisplatin-Associated Ototoxicity: A Review for the Health Professional
Cisplatin is an effective drug used in the treatment of many cancers, yet its ototoxic potential places cancer patients, exposed to this drug, at risk of hearing loss, thus negatively impacting further on a patient’s quality of life. It is paramount for health care practitioners managing such patien...
Saved in:
Main Authors: | Jessica Paken, Cyril D. Govender, Mershen Pillay, Vikash Sewram |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Toxicology |
Online Access: | http://dx.doi.org/10.1155/2016/1809394 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insight into the current practice of ototoxicity monitoring during cisplatin therapy
by: N. M. Santucci, et al.
Published: (2021-03-01) -
Possible Protective Effect of Sertraline against Cisplatin-Induced Ototoxicity: An Experimental Study
by: Murat Ozturk, et al.
Published: (2013-01-01) -
An Unusual Case of Ototoxicity with Use of Oral Vancomycin
by: Umut Gomceli, et al.
Published: (2018-01-01) -
Hair Cell Protection from Ototoxic Drugs
by: Peng Wu, et al.
Published: (2021-01-01) -
Prevalence of platinum-induced ototoxicity among patients suffering from hematological malignancies – a systematic review
by: Aleksandra Janowiak-Majeranowska, et al.
Published: (2024-07-01)